Get App Open
In App
Lending
Lending
Open App
you are here:

GlaxoSmithKline Pharmaceuticals Ltd.

BSE: 500660 | NSE: GLAXO |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE159A01016 | SECTOR: Pharmaceuticals & Drugs

BSE Live

Oct 09, 16:01
2758.60 30.80 (1.13%)
Volume
AVERAGE VOLUME
5-Day
1,762
10-Day
1,734
30-Day
2,321
2,565
  • Prev. Close

    2727.80

  • Open Price

    2735.65

  • Bid Price (Qty.)

    2721.85 (200)

  • Offer Price (Qty.)

    2828.00 (5)

NSE Live

Oct 09, 15:55
2761.00 31.40 (1.15%)
Volume
AVERAGE VOLUME
5-Day
67,531
10-Day
79,472
30-Day
84,217
81,394
  • Prev. Close

    2729.60

  • Open Price

    2730.00

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    2761.00 (100)

Financials

Cash Flow of GlaxoSmithKline Pharmaceuticals (in Rs. Cr.) Mar 25 Mar 24 Mar 23 Mar 22 Mar 21  
  12 mths 12 mths 12 mths 12 mths 12 mths  
Net Profit/Loss Before Extraordinary Items And Tax 1,243.74 809.04 837.49 2,470.04 722.33  
Net CashFlow From Operating Activities 1,280.03 578.93 487.94 819.79 594.87  
Net Cash Used In Investing Activities -36.53 14.97 805.19 -419.66 407.57  
Net Cash Used From Financing Activities -769.42 -561.49 -1,544.18 -524.24 -695.56  
Foreign Exchange Gains / Losses 0.00 0.00 0.00 0.00 0.00  
Adjustments On Amalgamation Merger Demerger Others 0.00 0.00 0.00 0.00 0.00  
Net Inc/Dec In Cash And Cash Equivalents 474.07 32.41 -251.05 -124.11 306.87  
Cash And Cash Equivalents Begin of Year 62.15 29.74 280.79 404.90 98.03  
Cash And Cash Equivalents End Of Year 536.22 62.15 29.74 280.79 404.90  
Source : Dion Global Solutions Limited